Pain News and Research

Latest Pain News and Research

Synthetic biomaterial aids in regeneration of skin cells to improve wound healing

Synthetic biomaterial aids in regeneration of skin cells to improve wound healing

Kitov announces more data from Phase III trial on the favorable blood pressure effects of KIT-302

Kitov announces more data from Phase III trial on the favorable blood pressure effects of KIT-302

Study examines effect of nonoperative treatment for appendicitis

Study examines effect of nonoperative treatment for appendicitis

Toronto researchers reveal how opioids interfere with breathing mechanism

Toronto researchers reveal how opioids interfere with breathing mechanism

Stem cell therapy not significantly better than conventional treatment for Crohn's disease

Stem cell therapy not significantly better than conventional treatment for Crohn's disease

Understanding how thought arises from brain structure

Understanding how thought arises from brain structure

Drug use remains stable among teens, MTF survey shows

Drug use remains stable among teens, MTF survey shows

Stanford study finds that overprescription of opioids goes beyond ‘pill mill’ prescribers

Stanford study finds that overprescription of opioids goes beyond ‘pill mill’ prescribers

Acupuncture may be safe, effective treatment for chronic pain in pediatric patients

Acupuncture may be safe, effective treatment for chronic pain in pediatric patients

Diseases that cause skin-related problems can also trigger serious neurological conditions

Diseases that cause skin-related problems can also trigger serious neurological conditions

High testosterone levels in women may increase uterine fibroid risk

High testosterone levels in women may increase uterine fibroid risk

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

Kitov Pharmaceuticals' KIT-302 drug candidate meets primary efficacy endpoint in Phase III clinical trial

Kitov Pharmaceuticals' KIT-302 drug candidate meets primary efficacy endpoint in Phase III clinical trial

Egalet submits NDA for ARYMO ER (morphine sulfate) extended-release tablets

Egalet submits NDA for ARYMO ER (morphine sulfate) extended-release tablets

Lupuzor may become first non-immunosuppressant therapy for lupus

Lupuzor may become first non-immunosuppressant therapy for lupus

New ICN Food List app can help people struggling with urinary tract food sensitivity

New ICN Food List app can help people struggling with urinary tract food sensitivity

Human body clock study paves way for drug treatment of osteoarthritis

Human body clock study paves way for drug treatment of osteoarthritis

ESSA reports net loss of $11.5 million for year ended September 30, 2015

ESSA reports net loss of $11.5 million for year ended September 30, 2015

Active individuals may need to maintain higher vitamin D levels to reduce risk of stress fractures

Active individuals may need to maintain higher vitamin D levels to reduce risk of stress fractures

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.